Karin Walker
SVP, Chief Accounting Officer @Prothena Corporation
Signup · Get unlimited contacts
WORK HISTORY
SVP, Chief Accounting Officer @Prothena Corporation
San Francisco, US
Prothena Corporation plc (“Prothena” or the “Company”) is a clinical-stage neuroscience company with expertise in protein misfolding, focused on the discovery and development of novel therapies with the potential to fundamentally change the course of devastating diseases.Fueled by our deep scientific expertise built over decades of research, the Company is advancing a pipeline of therapeutic candidates for a number of indications and novel targets for which our ability to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be leveraged. Prothena\'s partnered programs include prasinezumab (PRX002/RG7935), in collaboration with Roche for the potential treatment of Parkinson’s disease and other related synucleinopathies, and programs that target tau, TDP-43 and an undisclosed target in collaboration with Bristol-Myers Squibb for the potential treatment of Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) or other neurodegenerative diseases. The Company\'s proprietary programs include PRX004 for the potential treatment of ATTR amyloidosis, and programs that target Aβ (Amyloid beta) for the potential treatment of Alzheimer’s disease.
EDUCATION
California Polytechnic State University-San Luis Obispo
BS, Business / Finance
SKILLS
ABOUT KARIN WALKER
Seasoned and accomplished senior finance leader with 30 years financial management experience including CAO, CFO and Controller positions in public and private companies. Karin currently is Senior Vice President, Chief Accounting Officer at Prothena Corporation plc and served on the board of directors of Cyclacel Pharmaceutical Inc. and LifeSci Acquistion Corp.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.